Compare CYCN & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYCN | MTR |
|---|---|---|
| Founded | 2018 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 5.8M |
| IPO Year | N/A | N/A |
| Metric | CYCN | MTR |
|---|---|---|
| Price | $3.69 | $3.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 23.4K | 8.4K |
| Earning Date | 05-08-2026 | 03-31-2026 |
| Dividend Yield | N/A | ★ 4.82% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.60 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $3.06 |
| 52 Week High | $8.48 | $5.98 |
| Indicator | CYCN | MTR |
|---|---|---|
| Relative Strength Index (RSI) | 62.77 | 32.91 |
| Support Level | $2.93 | N/A |
| Resistance Level | $8.48 | $4.89 |
| Average True Range (ATR) | 0.22 | 0.08 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 66.65 | 26.47 |
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.